Cover Image
市場調查報告書

Molecular Design International, Inc.:產品平台分析

Molecular Design International, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 276022
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Molecular Design International, Inc.:產品平台分析 Molecular Design International, Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 22 Pages
簡介

Molecular Design International, Inc.是發明新藥及製藥、研發之生物科技企業。同時也從事新的發現與評估,及提供別家公司技術。該公司主要提供肥胖和糖尿病黃斑部水腫、皮膚病、腫瘤、慢性阻塞性肺病等治療藥。

本報告提供Molecular Design International, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

Molecular Design International, Inc.的基本資料

  • Molecular Design International, Inc.概要
  • 主要資訊
  • 企業資料

Molecular Design International, Inc.:R&D概要

  • 主要的治療範圍

Molecular Design International, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Molecular Design International, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Molecular Design International, Inc.:藥物簡介

  • 49-B
  • MDI-301
  • Small Molecules For Cancer
  • Small Molecules for Diabetes
  • Small Molecules to Agonize Beta3 Adrenoceptors for Obesity

Molecular Design International, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Molecular Design International, Inc.:暫停中的計劃

Molecular Design International, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07471CDB

Summary

Global Markets Direct's, 'Molecular Design International, Inc. - Product Pipeline Review - 2015', provides an overview of the Molecular Design International, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Molecular Design International, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Molecular Design International, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Molecular Design International, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Molecular Design International, Inc.'s pipeline products

Reasons to buy

  • Evaluate Molecular Design International, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Molecular Design International, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Molecular Design International, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Molecular Design International, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Molecular Design International, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Molecular Design International, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Molecular Design International, Inc. Snapshot
    • Molecular Design International, Inc. Overview
    • Key Information
    • Key Facts
  • Molecular Design International, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Molecular Design International, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Molecular Design International, Inc. - Pipeline Products Glance
  • Molecular Design International, Inc. - Early Stage Pipeline Products
  • Preclinical Products/Combination Treatment Modalities
  • Molecular Design International, Inc. - Drug Profiles
    • MDI-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules For Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Agonize Beta3 Adrenoceptors for Obesity
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Molecular Design International, Inc. - Pipeline Analysis
  • Molecular Design International, Inc. - Pipeline Products by Target
  • Molecular Design International, Inc. - Pipeline Products by Route of Administration
  • Molecular Design International, Inc. - Pipeline Products by Molecule Type
  • Molecular Design International, Inc. - Pipeline Products by Mechanism of Action
  • Molecular Design International, Inc. - Dormant Projects
  • Molecular Design International, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Molecular Design International, Inc., Key Information
  • Molecular Design International, Inc., Key Facts
  • Molecular Design International, Inc. - Pipeline by Indication, 2015
  • Molecular Design International, Inc. - Pipeline by Stage of Development, 2015
  • Molecular Design International, Inc. - Monotherapy Products in Pipeline, 2015
  • Molecular Design International, Inc. - Preclinical, 2015
  • Molecular Design International, Inc. - Pipeline by Target, 2015
  • Molecular Design International, Inc. - Pipeline by Route of Administration, 2015
  • Molecular Design International, Inc. - Pipeline by Molecule Type, 2015
  • Molecular Design International, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Molecular Design International, Inc. - Dormant Developmental Projects,2015

List of Figures

  • Molecular Design International, Inc. - Pipeline by Top 10 Indication, 2015
  • Molecular Design International, Inc. - Pipeline by Top 10 Target, 2015
  • Molecular Design International, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top